Inventurus Knowledge Solutions Limited's healthcare brand, IKS Health, has completed the acquisition of 100% of the share capital in Arai Solutions Private Limited for a total cash consideration of INR 11,00,00,000 (Indian Rupees Eleven Crores only). The Board of Directors had approved the transaction on May 13, 2026, and pursuant to a Regulation 30(7) update filed with BSE Limited and the National Stock Exchange of India Limited, the acquisition was confirmed as completed on May 14, 2026. With the completion of this transaction, Arai Solutions Private Limited has become a wholly-owned subsidiary of Inventurus Knowledge Solutions Limited.

About the Acquired Entity

Arai Solutions Private Limited (CIN: U58200KA2024PTC187134) is a private limited company incorporated on April 5, 2024, under the laws of India, with its registered office at D-37, Golden Enclave, Airport Road, Vimanapura, Bangalore, Karnataka, 560017, India. The company operates in the Information Technology Enabled Services (ITeS) industry and provides consultancy services related to artificial intelligence solutions across industries, including the healthcare space. Its specific areas of expertise include research and development in algorithms and architectures, deep learning, machine learning, generative AI, large language models, natural language processing, symbolic AI (including knowledge graphs and logic systems), hybrid AI solutions, AI for cybersecurity, and neural networks with hardware acceleration. The acquisition does not constitute a related party transaction, and the Promoter/Promoter Group of Inventurus Knowledge Solutions Limited has no interest in the entity being acquired.

Financial Profile of Arai Solutions

The following table presents the financial details of Arai Solutions Private Limited for FY 2025-26, as disclosed in the regulatory filing:

The revenue history of the target over the last three years is as follows:

Key Acquisition Details

The principal terms of the completed acquisition are summarised below:

Strategic Rationale

IKS Health currently possesses a four-layer healthcare AI stack encompassing EMR integration, platform orchestration, trust/compliance, and AI applications. ARAI's ontology introduces a critical knowledge layer to this existing framework, which the company states makes IKS Health the only full-stack player with proprietary domain intelligence at every level. ARAI's interconnected biomedical knowledge graphs, grounded in peer-reviewed research, feed a central reasoning engine that is directly mappable to IKS Health platform outputs. The acquisition is designed to accelerate the development of a full agentic AI technology stack, with capabilities to create a more efficient proprietary small language model, and is expected to enhance IKS Health's existing care management workflows and accelerate the company's AI R&D.

The following key areas are expected to benefit from accelerated platform development and reduced dependency on third-party AI infrastructure:

• Autonomous coding
• Clinical decisions
• Denial prevention
• Prior authorization reasoning
• Precision medicine

Leadership Perspectives

Sachin K. Gupta, Founder and Global CEO of IKS Health, stated that ARAI's clinical knowledge infrastructure makes IKS Health AI operational models "even more economical, reliable, auditable, and capable of reasoning." He added that uniting ARAI with IKS Health adds a "valuable and complementary layer" to the platform as the company scales its AI-driven and human-in-the-loop approach in line with evolving clinical and regulatory guidelines. Dr. Roland Haas, co-founder and CEO of ARAI, noted that IKS Health is positioned to disrupt the health tech industry by creating AI-driven systems of action, and expressed that ARAI is pleased to join forces as IKS Health extends into next-generation clinical and operational AI models. Dr. Asoke Talukder, co-founder and CAIO of ARAI, highlighted that ARAI's framework fills the critical AI infrastructure knowledge layer, reinforcing IKS Health's position as the only full-stack player with proprietary domain intelligence at every tier.

A key differentiator highlighted in the announcement is ARAI's explainable AI approach, which the company describes as converting "black box AI into glass box AI," enabling predictions that are transparent, explainable, and traceable. IKS Health was founded in 2006 and has been recognised by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with a DORA Award for "Augmenting Human Expertise with AI."

Inventurus Knowledge Solutions Limited has announced that the audio recording of its earnings conference call to discuss Q4 FY 2025-26 financial results is now available. The call was originally held on Thursday, May 14, 2026, at 8:30 AM India Standard Time. This disclosure was made on May 14, 2026, pursuant to Regulation 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Conference Call Details

The company facilitated the conference call to review the financial performance for the quarter ended March 31, 2026. The following table outlines the key details of the event:

Access to Recording

The audio recording of the conference call has been uploaded to the company's official investor relations portal. Stakeholders who were unable to attend the live session can now listen to the management's discussion and analysis of the quarterly results. The recording is accessible at the specific link provided on the Inventurus Knowledge Solutions website.

Regulatory Compliance

The announcement regarding the availability of the recording was filed in compliance with SEBI LODR Regulations. The communication was signed by Sameer Chavan, Company Secretary and Compliance Officer (Membership No. F7211), on May 14, 2026.